Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil … Biologics and biosimilars in Brazil – the strategic questions
The growth of the Brazilian market and economy is paralleled by the increase in counterfeiting activities. The enforcement of IP rights involves … Anti-counterfeiting: A Global Guide 2020
After the outbreak of the new Coronavirus (the cause for the COVID-19 disease) worldwide, there has been intense discussion on several legal … Coronavirus, the mark of an era: an analysis from the point of view of industrial property in Brazil
The Global Practice Guide, published by Chambers & Partners, includes outlines of national regimes, fundamental laws, sectoral or special issues, workplace privacy, … Data Protection & Privacy in Brazil 2020: Global Practice Guide by Chambers & Partners
The Global Practice Guide, published by Chambers & Partners, provides guidance on intellectual property rights, initiating lawsuits, infringement, revocation/cancellation, trial and settlement, … Patent Litigation in Brazil 2020: Global Practice Guide by Chambers & Partners
A Q&A guide to privacy in Brazil. This Q&A guide gives a high-level overview of privacy rules and principles, including what national … Privacy in Brazil 2020
Brazil has recently seen important developments in its data protection regulation. The country’s fragmented regulation – which revealed a lack of legal … Brazil’s Best Counsel 2020 – Chapter Opening: Data Protection
A Q&A guide to pharmaceutical IP and competition law in Brazil. The Q&A gives a high level overview of key issues including … Pharmaceutical IP and competition law in Brazil: 2019
The growth of the Brazilian market and economy is paralleled by the increase in counterfeiting activities. The enforcement of IP rights involves … Anti-counterfeiting: A Global Guide 2019
Amylin analogs are important adjunctive drugs in the treatment of diabetes mellitus. However, a dual therapy with insulin involves inconvenient multiple injections. … BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats
